SAN ANTONIO - New drug combinations are helping women with early breast cancer. Using two drugs that more precisely target tumors doubled the number of women whose cancer disappeared compared with those who had only one of the drugs, doctors reported Friday.

It was the first test of Herceptin and Tykerb together for early-stage disease. They aim at a protein called HER-2 that is overproduced in about one-fourth of all breast cancers. Herceptin blocks the protein on the cell's surface; Tykerb does it inside the cell... Read More